Vivas-Valencia Carolina, Kong Nan, Adams Nicole, Griffin Paul M
Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana, USA.
School of Nursing, Purdue University, West Lafayette, Indiana, USA.
Health Equity. 2023 Feb 1;7(1):76-79. doi: 10.1089/heq.2021.0154. eCollection 2023.
Health care disparities based on race/ethnicity and sex can be found in a variety of settings. Our aim is to determine if there are disparities in treatment provided to Indiana Medicaid enrollees who have medically documented opioid use.
We used Medicaid reimbursement claims data to extract patients who were diagnosed with opioid use disorder (OUD) or had other medical event related to opioid use between January 2018 and March 2019. We used a two-proportion -test to verify the difference in the proportion of treatment provided between population subgroups. The study was approved by the Purdue University Institutional Review Board (2019-118).
Over the study period, there were 52,994 Indiana Medicaid enrollees diagnosed with OUD or documentation of another opioid related event. Only 5.41% of them received at least one type of treatment service (detoxification, psychosocial, medication assisted treatment, or comprehensive).
Although Medicaid began covering treatment services for enrollees with an OUD in Indiana at the start of 2018, very few received evidence-based services. Men and White enrollees with an OUD were in general more likely to receive services compared to women and non-White enrollees.
基于种族/族裔和性别的医疗保健差异在多种情况下都存在。我们的目的是确定在印第安纳州医疗补助计划参保者中，那些有医学记录的阿片类药物使用者在接受治疗方面是否存在差异。
我们使用医疗补助报销申请数据，提取了在2018年1月至2019年3月期间被诊断为患有阿片类药物使用障碍（OUD）或有其他与阿片类药物使用相关医疗事件的患者。我们使用双比例检验来验证不同人群亚组之间接受治疗比例的差异。该研究获得了普渡大学机构审查委员会的批准（2019 - 118）。
在研究期间，有52994名印第安纳州医疗补助计划参保者被诊断为患有OUD或有其他与阿片类药物相关事件的记录。其中只有5.41%的人接受了至少一种类型的治疗服务（戒毒、心理社会治疗、药物辅助治疗或综合治疗）。
尽管印第安纳州医疗补助计划从2018年初开始为患有OUD的参保者提供治疗服务，但很少有人接受循证服务。与女性和非白人参保者相比，患有OUD的男性和白人参保者通常更有可能接受服务。
